May 15th 2024
Your daily dose of the clinical news you may have missed.
Metabolically Healthy Obesity May Increase Risk of Heart Failure, but Not Heart Attack or Stroke
October 5th 2021EASD 2021: Patients with metabolically healthy obesity are nearly 33% more likely to develop heart failure and atrial fibrillation than healthy persons of normal weight, suggests new analysis.
SGLT2 Inhibitor Empagliflozin Found Safe, Effective for HFpEF in Landmark EMPORER-Preserved Trial
July 7th 2021Empagliflozin, already indicated to improve outcomes in patients with HFrEF, reduced risk of a composite of CV death or hospitalization for HF in adults HFpEF, marking a potential therapeutic milestone.